CADUET ® 5/10

Country: Iżrael

Lingwa: Ingliż

Sors: Ministry of Health

Ingredjent attiv:

AMLODIPINE AS BESYLATE 5 MG; ATORVASTATIN AS CALCIUM 10 MG

Disponibbli minn:

PFIZER PHARMACEUTICALS ISRAEL LTD

Kodiċi ATC:

C08CA01

Għamla farmaċewtika:

FILM COATED TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

PFIZER MANUFACTURING DEUTSCHLAND GMBH, GERMANY

Grupp terapewtiku:

AMLODIPINE

Indikazzjonijiet terapewtiċi:

Caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. Amlodipine: - Hypertension - Chronic stable angina - Vasospastic angina (Prinzmetal's or variant angina). Atorvastatin : - Prevention of cardiovascular disease - Heterozygous familial and nonfamilial hypercholesterolemia - Elevated serum TG levels - Primary dysbetalipoproteinemia - Homozygous familial hypercholesterolemia - Pediatric patients (10-17 years of age) : Atorvastatin is indicated as an adjunct to diet to reduce total -C LDL-C and apo B levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. LDL-C remains >or = 190 mg/dl or 2. LDL-C remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the pediatric patient.

Data ta 'l-awtorizzazzjoni:

2011-08-01